MEP36808A - Ambroxol-containing lozenge - Google Patents

Ambroxol-containing lozenge

Info

Publication number
MEP36808A
MEP36808A MEP-368/08A MEP36808A MEP36808A ME P36808 A MEP36808 A ME P36808A ME P36808 A MEP36808 A ME P36808A ME P36808 A MEP36808 A ME P36808A
Authority
ME
Montenegro
Prior art keywords
ambroxol
containing lozenge
lozenge
relates
new type
Prior art date
Application number
MEP-368/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Ulrich Maerz Dr Frieder
Hans-Hermann Von Der Heydt Dr Holger
Schmitt Horst
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7914872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP36808(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MEP36808A publication Critical patent/MEP36808A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dry Formation Of Fiberboard And The Like (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
MEP-368/08A 1999-07-20 2000-07-07 Ambroxol-containing lozenge MEP36808A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19933148A DE19933148A1 (de) 1999-07-20 1999-07-20 Ambroxolhaltige Lutschtablette
PCT/EP2000/006437 WO2001005378A1 (de) 1999-07-20 2000-07-07 Ambroxolhaltige lutschtablette
YU3802A RS50246B (sr) 1999-07-20 2000-07-07 Tableta za sisanje, koja sadrži ambroksol

Publications (1)

Publication Number Publication Date
MEP36808A true MEP36808A (en) 2011-02-10

Family

ID=7914872

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-368/08A MEP36808A (en) 1999-07-20 2000-07-07 Ambroxol-containing lozenge

Country Status (33)

Country Link
US (1) US6663889B1 (zh)
EP (2) EP1200070B1 (zh)
JP (1) JP3776041B2 (zh)
KR (1) KR100743846B1 (zh)
CN (1) CN1164263C (zh)
AT (1) ATE246493T1 (zh)
AU (1) AU776906B2 (zh)
BG (1) BG65503B1 (zh)
BR (1) BRPI0012553B8 (zh)
CA (1) CA2379314C (zh)
CZ (1) CZ301981B6 (zh)
DE (2) DE19933148A1 (zh)
DK (1) DK1200070T3 (zh)
EA (1) EA004044B1 (zh)
EE (1) EE04797B1 (zh)
ES (1) ES2173823T3 (zh)
HK (1) HK1045946B (zh)
HR (1) HRP20020050B1 (zh)
HU (1) HU229040B1 (zh)
IL (2) IL147261A0 (zh)
ME (1) MEP36808A (zh)
MX (1) MXPA02000546A (zh)
NO (1) NO331306B1 (zh)
NZ (1) NZ516987A (zh)
PL (1) PL197175B1 (zh)
PT (1) PT1200070E (zh)
RS (1) RS50246B (zh)
SI (1) SI1200070T1 (zh)
SK (1) SK284290B6 (zh)
TR (1) TR200200106T2 (zh)
UA (1) UA73313C2 (zh)
WO (1) WO2001005378A1 (zh)
ZA (1) ZA200200384B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
DE102005018561A1 (de) * 2005-04-21 2006-11-02 Giesecke & Devrient Gmbh Verfahren zum Betreiben eines Systems mit einem tragbaren Datenträger und einem Endgerät
DE102010009369A1 (de) 2010-02-25 2011-08-25 Boehringer Ingelheim International GmbH, 55218 Kindergesicherte Verpackung für Ambroxolhaltige Lutschtabletten
NZ609742A (en) 2010-12-23 2015-01-30 Lectio Pharmaentwicklungs Und Verwertungs Gmbh Aqueous solution of ambroxol
KR102076585B1 (ko) 2011-12-22 2020-02-12 센토제너 아이피 게엠베하 리소좀 효소를 재배열하는 능력을 갖는 화합물 및 암브록솔 및/또는 암브록솔의 유도체의 조합물
US10265280B2 (en) 2016-11-14 2019-04-23 Mingwu Wang Formulations for the treatment of ocular surface diseases and related methods
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (de) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen
EP0138020B1 (de) * 1983-09-17 1992-06-03 Dr. Karl Thomae GmbH Antiadhäsive Prophylactica und Arzneimittel enthaltend ein sekretolytisch wirksames Benzylaminderivat
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt

Also Published As

Publication number Publication date
SI1200070T1 (en) 2003-12-31
EP1200070A1 (de) 2002-05-02
SK812002A3 (en) 2002-06-04
BG65503B1 (bg) 2008-10-31
TR200200106T2 (tr) 2002-07-22
JP2003522125A (ja) 2003-07-22
HUP0202021A3 (en) 2004-05-28
EE200200027A (et) 2003-04-15
WO2001005378A1 (de) 2001-01-25
ES2173823T1 (es) 2002-11-01
CA2379314A1 (en) 2001-01-25
HRP20020050B1 (en) 2004-06-30
DE50003209D1 (de) 2003-09-11
NO20020274D0 (no) 2002-01-18
UA73313C2 (uk) 2005-07-15
YU3802A (sh) 2004-09-03
CZ301981B6 (cs) 2010-08-25
JP3776041B2 (ja) 2006-05-17
US6663889B1 (en) 2003-12-16
BR0012553B1 (pt) 2014-05-27
NO331306B1 (no) 2011-11-21
BG106316A (en) 2002-08-30
NO20020274L (no) 2002-03-13
SK284290B6 (sk) 2005-01-03
HRP20020050A2 (en) 2003-06-30
AU776906B2 (en) 2004-09-23
HUP0202021A2 (hu) 2002-11-28
AU6269900A (en) 2001-02-05
PL352276A1 (en) 2003-08-11
EP1352646A2 (de) 2003-10-15
CN1364075A (zh) 2002-08-14
HU229040B1 (en) 2013-07-29
DE19933148A1 (de) 2001-01-25
MXPA02000546A (es) 2002-07-30
PL197175B1 (pl) 2008-03-31
BR0012553A (pt) 2002-04-16
CZ20014633A3 (cs) 2002-03-13
CN1164263C (zh) 2004-09-01
HK1045946A1 (en) 2002-12-20
BRPI0012553B8 (pt) 2021-05-25
IL147261A0 (en) 2002-08-14
NZ516987A (en) 2003-08-29
RS50246B (sr) 2009-07-15
ES2173823T3 (es) 2004-04-16
KR100743846B1 (ko) 2007-08-02
PT1200070E (pt) 2003-12-31
HK1045946B (zh) 2005-01-28
EP1200070B1 (de) 2003-08-06
CA2379314C (en) 2007-09-11
ZA200200384B (en) 2002-10-30
ATE246493T1 (de) 2003-08-15
EP1352646A3 (de) 2004-01-07
DK1200070T3 (da) 2003-10-06
EA004044B1 (ru) 2003-12-25
EE04797B1 (et) 2007-04-16
EA200200091A1 (ru) 2002-06-27
IL147261A (en) 2006-12-31
KR20020012316A (ko) 2002-02-15

Similar Documents

Publication Publication Date Title
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1999000154A (es) 1,2,3,4 tetrahidroquinolinas 2 sustituidas 4 - carboxiamino sustituidas.
LU93311I2 (fr) Mancozèbe, valifenalate
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
PT1193270E (pt) Pirrolobenzodiazepinas
SV2002000356A (es) Nuevos derivados de piperazina ref. pc10770aixn/bb
CY1107400T1 (el) Συνταγοποιηση κοκκου μοντελουκαστης
HN1998000175A (es) Imidazotriazininas
TR200200460T2 (tr) Yeni fenilpiperazinler
CY1108567T1 (el) Αντιθρομβωτικες ενωσεις
MEP36808A (en) Ambroxol-containing lozenge
HN1997000098A (es) Ccompuesto de indol 2, 3 sustituido como agentes antiinflamatorios y analgesicos.
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
SE9901077D0 (sv) Novel use
YU11401A (sh) Lokalne farmaceutske kompozicije koje sadrže nimesulid
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
BR0007922A (pt) Compostos calcilìticos
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития
AR037961A1 (es) Aminoplastico compuesto termofraguable, resistente a los rayos uv, su fabricacion y uso
ITMI20000293A0 (it) Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica
DE50107490D1 (de) Stoffgemisch enthaltend bisphenol a
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ATE249204T1 (de) Spray, enthaltend ubichinon qn
TR200102093T2 (tr) Organ koruyucu çözeltiler